193 related articles for article (PubMed ID: 36608921)
1. Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulonephropathy Network.
Chen DP; Helmuth ME; Smith AR; Canetta PA; Ayoub I; Mucha K; Kallash M; Kopp JB; Gbadegesin R; Gillespie BW; Greenbaum LA; Parekh RS; Hunley TE; Sperati CJ; Selewski DT; Kidd J; Chishti A; Reidy K; Mottl AK; Gipson DS; Srivastava T; Twombley KE;
Am J Kidney Dis; 2023 Jun; 81(6):695-706.e1. PubMed ID: 36608921
[TBL] [Abstract][Full Text] [Related]
2. CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.
Mariani LH; Bomback AS; Canetta PA; Flessner MF; Helmuth M; Hladunewich MA; Hogan JJ; Kiryluk K; Nachman PH; Nast CC; Rheault MN; Rizk DV; Trachtman H; Wenderfer SE; Bowers C; Hill-Callahan P; Marasa M; Poulton CJ; Revell A; Vento S; Barisoni L; Cattran D; D'Agati V; Jennette JC; Klein JB; Laurin LP; Twombley K; Falk RJ; Gharavi AG; Gillespie BW; Gipson DS; Greenbaum LA; Holzman LB; Kretzler M; Robinson B; Smoyer WE; Guay-Woodford LM;
Am J Kidney Dis; 2019 Feb; 73(2):218-229. PubMed ID: 30420158
[TBL] [Abstract][Full Text] [Related]
3. Clinico-biochemical Profile of Biopsy-proven Minimal Change Disease in Adults from a Tertiary Care Center in South India.
Udupa KRN; Eshwarappa M; Gurudev KC; Gireesh MS; Reddy R; Yousuff M
Saudi J Kidney Dis Transpl; 2023 May; 34(3):242-249. PubMed ID: 38231719
[TBL] [Abstract][Full Text] [Related]
4. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
Alshami A; Roshan A; Catapang M; Jöbsis JJ; Kwok T; Polderman N; Sibley J; Sibley M; Mammen C; Matsell DG;
Pediatr Nephrol; 2017 Oct; 32(10):1897-1905. PubMed ID: 28540445
[TBL] [Abstract][Full Text] [Related]
5. Interventions for minimal change disease in adults with nephrotic syndrome.
Azukaitis K; Palmer SC; Strippoli GF; Hodson EM
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD001537. PubMed ID: 35230699
[TBL] [Abstract][Full Text] [Related]
6. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
Maas RJ; Deegens JK; Beukhof JR; Reichert LJ; Ten Dam MA; Beutler JJ; van den Wall Bake AWL; Rensma PL; Konings CJ; Geerse DA; Feith GW; Van Kuijk WH; Wetzels JF
Am J Kidney Dis; 2017 May; 69(5):637-646. PubMed ID: 28089478
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of biopsy-proven minimal change nephropathy in Chinese adults.
Szeto CC; Lai FM; Chow KM; Kwan BC; Kwong VW; Leung CB; Li PK
Am J Kidney Dis; 2015 May; 65(5):710-8. PubMed ID: 25465164
[TBL] [Abstract][Full Text] [Related]
8. Quantification of Glomerular Structural Lesions: Associations With Clinical Outcomes and Transcriptomic Profiles in Nephrotic Syndrome.
Hodgin JB; Mariani LH; Zee J; Liu Q; Smith AR; Eddy S; Hartman J; Hamidi H; Gaut JP; Palmer MB; Nast CC; Chang A; Hewitt S; Gillespie BW; Kretzler M; Holzman LB; Barisoni L;
Am J Kidney Dis; 2022 Jun; 79(6):807-819.e1. PubMed ID: 34864148
[TBL] [Abstract][Full Text] [Related]
9. Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study.
Wang CS; Glenn DA; Helmuth M; Smith AR; Bomback AS; Canetta PA; Coppock GM; Khalid M; Tuttle KR; Bou-Matar R; Greenbaum LA; Robinson BM; Holzman LB; Smoyer WE; Rheault MN; Gipson D; Mariani LH;
Am J Kidney Dis; 2024 Jan; 83(1):37-46. PubMed ID: 37657635
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Rituximab for Minimal Change Disease and Focal Segmental Glomerulosclerosis with Frequently Relapsing or Steroid-Dependent Nephrotic Syndrome in Adults: A Chinese Multicenter Retrospective Study.
Lan L; Lin Y; Yu B; Wang Y; Pan H; Wang H; Lou X; Lang X; Zhang Q; Jin L; Yang Y; Xiao L; Chen J; Han F
Am J Nephrol; 2024; 55(1):25-36. PubMed ID: 37963441
[TBL] [Abstract][Full Text] [Related]
11. Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS.
Osterholt T; Todorova P; Kühne L; Ehren R; Weber LT; Grundmann F; Benzing T; Brinkkötter PT; Völker LA
Sci Rep; 2023 Apr; 13(1):6980. PubMed ID: 37117201
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of low-dose rituximab in minimal change disease and prevention of relapse.
Zhang J; Zhao H; Li X; Qian R; Gao P; Lu S; Ma Z
BMC Nephrol; 2023 Apr; 24(1):112. PubMed ID: 37101300
[TBL] [Abstract][Full Text] [Related]
13. [Renal function in subjects with minimal change steroid-responsive nephrotic syndrome in childhood].
Strzelecka-Lichota A
Ann Acad Med Stetin; 2004; 50(2):41-9. PubMed ID: 16529164
[TBL] [Abstract][Full Text] [Related]
14. Comparison between patients with IgA nephropathy with minimal change disease and patients with minimal change disease.
Li XW; Cheng SQ; Liang SS; Le WB; Zeng CH; Wang JQ; Liu ZH
Clin Nephrol; 2016 May; 85(5):273-81. PubMed ID: 26951969
[TBL] [Abstract][Full Text] [Related]
15. CureGN-Diabetes Study: Rationale, Design, and Methods of a Prospective Observational Study of Glomerular Disease Patients with Diabetes.
Mottl AK; Bomback AS; Mariani LH; Coppock G; Jennette JC; Almaani S; Gipson DS; Kelley S; Kidd J; Laurin LP; Mucha K; Oliverio A; Palmer M; Rizk D; Sanghani N; Stokes MB; Susztak K; Wadhwani S; Nast CC
Glomerular Dis; 2023; 3(1):155-164. PubMed ID: 37901700
[TBL] [Abstract][Full Text] [Related]
16. Adult-onset minimal change disease among Taiwanese: clinical features, therapeutic response, and prognosis.
Huang JJ; Hsu SC; Chen FF; Sung JM; Tseng CC; Wang MC
Am J Nephrol; 2001; 21(1):28-34. PubMed ID: 11275629
[TBL] [Abstract][Full Text] [Related]
17. Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance.
Guitard J; Hebral AL; Fakhouri F; Joly D; Daugas E; Rivalan J; Guigonis V; Ducret F; Presne C; Pirson Y; Hourmant M; Glachant JC; Vendrely B; Moranne O; Faguer S; Chauveau D
Nephrol Dial Transplant; 2014 Nov; 29(11):2084-91. PubMed ID: 24920841
[TBL] [Abstract][Full Text] [Related]
18. Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis.
Hansrivijit P; Cheungpasitporn W; Thongprayoon C; Ghahramani N
BMC Nephrol; 2020 Apr; 21(1):134. PubMed ID: 32293308
[TBL] [Abstract][Full Text] [Related]
19. Short-Term Steroid Regimen for Adult Steroid-Sensitive Minimal Change Disease.
Ozeki T; Katsuno T; Hayashi H; Kato S; Yasuda Y; Ando M; Tsuboi N; Hagiwara D; Arima H; Maruyama S
Am J Nephrol; 2019; 49(1):54-63. PubMed ID: 30557879
[TBL] [Abstract][Full Text] [Related]
20. Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings.
Pelletier JH; Kumar KR; Engen R; Bensimhon A; Varner JD; Rheault MN; Srivastava T; Straatmann C; Silva C; Davis TK; Wenderfer SE; Gibson K; Selewski D; Barcia J; Weng P; Licht C; Jawa N; Kallash M; Foreman JW; Wigfall DR; Chua AN; Chambers E; Hornik CP; Brewer ED; Nagaraj SK; Greenbaum LA; Gbadegesin RA
Pediatr Nephrol; 2018 Oct; 33(10):1773-1780. PubMed ID: 29982878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
